Skip to main content

Table 2 Demographic, clinical, and laboratory data

From: Analysis of selected polymorphisms in FOXP3 gene in a cohort of Egyptian patients with schizophrenia

Age years (mean ± SD)

32.45 ± 9.167

Gender: male/female

54/71

Duration of illness: years (mean ± SD)

9.48 ± 6.875

Family history: no/yes

78/47

Smoking: no/yes

49/76

Marital status: single/married/divorced

71/34/20

Antipsychotic medication: no/yes

22/103

Mood stabilizer: no/yes

93/32

Antidepressant: no/yes

77/48

Diabetes/hypertension: no/yes

117/8

Positive scale 7–49 (mean ± SD)

16.66 ± 4.675

Negative scale 7–49 (mean ± SD)

19.30 ± 15.939

General psychopathology 16–112 (mean ± SD)

55.54 ± 27.286

Total score

91.48 ± 30.815

HB g/dl (mean ± SD)

15.362 ± 15.546

Wbcs 109/l (mean ± SD)

7.215 ± 1.824

Platelets 109/l (mean ± SD)

228.79 ± 87.216

ALT U/l (mean ± SD)

25.47 ± 14.229

Glucose mg/dl (mean ± SD)

93.98 ± 19.122

Creatinine mg/dl (mean ± SD)

0.980 ± 0.4879

Cholesterol mg/dl (mean ± SD)

190.55 ± 133.152

  1. SD standard deviation